MSL
CSII

Mackay Shields LLC’s Cardiovascular Systems, Inc. CSII Stock Holding History

Mackay Shields LLC’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-92,800
Closed -$3.98M – 1525
2019
Q2 		$3.98M Buy
+92,800
New +$3.6M 0.03% 626

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackay Shields LLC's CSII Position: Q3 2019 in Review

Mackay Shields LLC sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2019, closing a stake of 92,800 shares — an estimated $3.98M sold.

Mackay Shields LLC first reported a position in CSII in Q2 2019 and held it in 1 quarter. The position peaked at $3.98M in Q2 2019. 190 funds tracked by Wall St. Rank hold CSII as of Q3 2019.

  • Mackay Shields LLC reported no remaining Cardiovascular Systems, Inc. position as of Q3 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 92,800 Cardiovascular Systems, Inc. shares in Q3 2019, an estimated $3.98M.
  • Mackay Shields LLC first reported a position in Cardiovascular Systems, Inc. in Q2 2019 and held it in 1 quarter.
  • Mackay Shields LLC's Cardiovascular Systems, Inc. position peaked at $3.98M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2019.

Based on Mackay Shields LLC's 13F filing for Q3 2019, filed 1 Nov 2019.